Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway
出版年份 2023 全文链接
标题
Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway
作者
关键词
-
出版物
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-05-24
DOI
10.1038/s41401-023-01106-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice
- (2022) Mengyun Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fisetin protects against high fat diet-induced nephropathy by inhibiting inflammation and oxidative stress via the blockage of iRhom2/NF-κB signaling
- (2021) Ge Chenxu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Fisetin Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Macrophage
- (2021) Yoshiko Hada et al. Biomed Research International
- TGF-Beta as a Master Regulator of Diabetic Nephropathy
- (2021) Li Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fisetin prevents oxidized low-density lipoproteins induced macrophage foam cell formation
- (2021) Johnna Francis Varghese et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Introduction: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Mycobacterium tuberculosis RKIP (Rv2140c) dephosphorylates ERK/NF-κB upstream signaling molecules to subvert macrophage innate immune response
- (2021) M.A. Abo-Kadoum et al. INFECTION GENETICS AND EVOLUTION
- Fisetin alleviates sepsis-induced multiple organ dysfunction in mice via inhibiting p38 MAPK/MK2 signaling
- (2020) Hai-feng Zhang et al. ACTA PHARMACOLOGICA SINICA
- Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy
- (2019) Osama Y. Althunibat et al. LIFE SCIENCES
- Gpihbp1 deficiency accelerates atherosclerosis and plaque instability in diabetic Ldlr-/- mice
- (2019) Xuejing Liu et al. ATHEROSCLEROSIS
- Induction of endothelial dysfunction by oxidized low-density lipoproteins via downregulation of Erk-5/Mef2c/KLF2 signaling: Amelioration by fisetin
- (2019) Rohit Patel et al. BIOCHIMIE
- Therapeutic potential of NaoXinTong Capsule on the developed diabetic nephropathy in db/db mice
- (2019) Shu Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications
- (2019) Elisa Dal Canto et al. European Journal of Preventive Cardiology
- Atherosclerosis and inflammation: overview and updates
- (2018) Glaucylara Reis Geovanini et al. CLINICAL SCIENCE
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
- (2018) N.H. Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The CD36-PPARγ Pathway in Metabolic Disorders
- (2018) Loïze Maréchal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fisetin is a senotherapeutic that extends health and lifespan
- (2018) Matthew J. Yousefzadeh et al. EBioMedicine
- CD36 plays a critical role in proliferation, migration and tamoxifen-inhibited growth of ER-positive breast cancer cells
- (2018) Yu Liang et al. Oncogenesis
- New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis
- (2018) Ting Yuan et al. Redox Biology
- CD36 in chronic kidney disease: novel insights and therapeutic opportunities
- (2017) Xiaochun Yang et al. Nature Reviews Nephrology
- Clinical Update: Cardiovascular Disease in Diabetes Mellitus
- (2016) Cecilia C. Low Wang et al. CIRCULATION
- Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen
- (2016) Miao Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A mechanistic link between renal ischemia and fibrosis
- (2016) Tetsuhiro Tanaka Medical Molecular Morphology
- Fisetin inhibits TNF-α-induced inflammatory action and hydrogen peroxide-induced oxidative damage in human keratinocyte HaCaT cells through PI3K/AKT/Nrf-2-mediated heme oxygenase-1 expression
- (2015) Seung-Hee Seo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake
- (2015) Xiaoxiao Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats
- (2014) Gopalan Sriram Prasath et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Fisetin inhibits high-glucose-induced vascular inflammation in vitro and in vivo
- (2014) Soyoung Kwak et al. INFLAMMATION RESEARCH
- Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation
- (2014) Szu-Yuan Li et al. KIDNEY INTERNATIONAL
- Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function
- (2013) E. I. Ekinci et al. DIABETES CARE
- Fisetin: A Dietary Antioxidant for Health Promotion
- (2012) Naghma Khan et al. ANTIOXIDANTS & REDOX SIGNALING
- Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice
- (2012) Yoshimi Takamiya et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- TGF-β/Smad Signaling in Kidney Disease
- (2012) Hui Y. Lan et al. SEMINARS IN NEPHROLOGY
- AGE–RAGE interaction and oxidative stress in obesity-related renal dysfunction
- (2011) Yasuhiko Tomino et al. KIDNEY INTERNATIONAL
- Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
- (2010) Ahmed A. Elmarakby et al. Cardiovascular Therapeutics
- Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms’ tumor-1 protein used as a podocyte marker
- (2009) Jian Su et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages
- (2008) Tzi-Wei Lian et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- THE AGE/RAGE AXIS IN DIABETES-ACCELERATED ATHEROSCLEROSIS
- (2008) Karin Jandeleit-Dahm et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started